Table 5.
Study | Calcineurin inhibitors | Length | Glomerular filtration rate gain (mL/min) |
US09 | TAC | 6 mo | +2.8 |
De Sevaux | CsA | 6 mo | +4.0 |
CAESAR Study | CsA | 12 mo | +2.3 |
SYMPHONY Study | TAC vs CsA | 3 yr | +4.6 |
A2309 | CsA | 12 mo | +1.9 |
ASSET Study | TAC | 12 mo | +5.3 |
B156 | CsA | 3 yr | +4.9 |
EVEREST | CsA | 6 mo | +2.1 |
CsA: Cyclosporine; TAC: Tacrolimus.